rs386833909
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PP3PP5_Very_Strong
The NM_004646.4(NPHS1):c.2227C>T(p.Arg743Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,613,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_004646.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPHS1 | ENST00000378910.10 | c.2227C>T | p.Arg743Cys | missense_variant | Exon 17 of 29 | 1 | NM_004646.4 | ENSP00000368190.4 | ||
NPHS1 | ENST00000585400.1 | n.918C>T | non_coding_transcript_exon_variant | Exon 3 of 3 | 1 | |||||
NPHS1 | ENST00000353632.6 | c.2227C>T | p.Arg743Cys | missense_variant | Exon 17 of 28 | 5 | ENSP00000343634.5 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251448Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135900
GnomAD4 exome AF: 0.000117 AC: 171AN: 1461760Hom.: 0 Cov.: 31 AF XY: 0.0000935 AC XY: 68AN XY: 727178
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74364
ClinVar
Submissions by phenotype
Finnish congenital nephrotic syndrome Pathogenic:7
- -
- -
- -
Variant summary: NPHS1 c.2227C>T (p.Arg743Cys) results in a non-conservative amino acid change located in the Spacer region between Ig-6 and Ig-7 domains (Liu_2001) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 251448 control chromosomes. c.2227C>T has been reported in the literature in multiple individuals affected with Nephrotic Syndrome, Type 1 (example, Lenkkeri_1999, Patrakka_2000, Liu_2001, Kari_2014, Bierzynska_2017, Machuca_2010). These data indicate that the variant is very likely to be associated with disease. Several publications report experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in ERAD (endoplasmic reticulum associated degradation) while not impacting trafficking to the cell surface (example, Drozova_2013, Miyai_2014, Yoshida_2021). Endoplasmic reticulum associated degradation is required for nephrin maturation and kidney glomerular filtration function (Yoshida_2021). Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic (n=1)/likely pathogenic (n=4). Some submitters cite overlapping evidence utilized in the context of this evaluation. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
- -
not provided Pathogenic:2
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 743 of the NPHS1 protein (p.Arg743Cys). This variant is present in population databases (rs386833909, gnomAD 0.008%). This missense change has been observed in individuals with congenital nephrotic syndrome (PMID: 9915943, 10972661, 20172850, 20507940, 24902943, 28117080). ClinVar contains an entry for this variant (Variation ID: 56469). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on NPHS1 protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on NPHS1 function (PMID: 11726550, 24142548, 24303155). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 32377865, 24142548, 11726550, 24303155, 33591954, 9915943, 24902943, 35372954, 11854170, 33089377, 20172850, 28117080, 10972661, 20507940) -
Nephrotic syndrome Pathogenic:1
This individual is homozygous for the c.2227C>T p.(Arg743Cys) variant in the NPHS1 gene. This variant has been reported in the ExAC database (http://exac.broadinstitute.org) with a very low allele frequency of 0.0016% (2 out of 121,386 alleles). It has also been reported in compound heterozygote state in mulitple patients with congenital nephrotic syndrome of Finnish type (see references). In addition, in vitro studies found that the p.Arg732Cys mutant peptide did not fold correctly and was rapidly degraded in the endoplasmic reticulum (Drozdova et al. 2013 Physiol Rep 1:e00086). In silico analysis of pathogenicity (through Alamut Visual v.2.8.1) using PolyPhen2, SIFT and MutationTaster all predict that this variant is likely to be pathogenic. This variant is considered to be pathogenic according to the ACMG guidelines. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at